Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
about
Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model.Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.Immunological basis in the pathogenesis and treatment of bladder cancerBacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder.Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.Immune therapies in non-muscle invasive bladder cancer.Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.
P2860
Q33563230-CDBD6B0F-A6A5-45EB-83BE-BE7416C9E492Q34320612-DFFE8A6F-447E-42CC-BB6E-4B018A2CAE9FQ35440552-6E924ABF-E3B5-47C8-B90A-996115772C9FQ35944928-99519608-6F92-4462-B967-980B9060C82AQ36056007-471D42A4-A9AC-4D93-92F1-8681E697E06EQ36260118-643EC781-51CE-41BD-8A45-6973126C6994Q37352975-B6A786B7-E8C7-43AB-8A82-6CAC3C5F5645Q37655607-36D52AA2-119B-4D56-B341-E9E4A3AB687DQ37773294-20C30FB4-0464-4879-B53C-FE2B63CADCBFQ38372571-DAFD6390-4C03-4E8C-81E7-BEDED4886C1CQ39017796-CF1F3044-10A1-431F-8780-5049DA0DE1D6
P2860
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
type
label
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
prefLabel
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
P2093
P2860
P1433
P1476
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
@en
P2093
Mark P Simons
Thomas S Griffith
William M Nauseef
P2860
P2888
P356
10.1007/S12026-007-0084-1
P577
2007-01-01T00:00:00Z